4/22
Health Sciences
Spiritual coping behaviors may be key to enhanced trauma recovery of Black men who survive firearm injury
A new study from Penn Nursing explores the complex role of spirituality as a coping mechanism for the burden of trauma.
An unsolved mystery: Why are we sleepy when sick?
David Raizen, a professor of neurology, alongside PURM student Hina Sako, spent the summer moving forward research examining how sickness affects sleep.
Deans of health schools discuss climate change in their fields
Deans and leaders from the schools of Medicine, Veterinary Medicine, Dental Medicine, Nursing, and Social Policy & Practice discussed climate and health at a Climate Week event.
The brain-blood barrier’s role in governing ant behavior
New research from Penn Medicine uncovers a link between a single enzyme and complex social behaviors in ants.
Removing the barrier surrounding solid tumors clears path for T cells
Penn researchers uncover a new way to target solid tumors. Using CAR T cells to remove cancer-associated fibroblasts surrounding pancreatic tumors allows T cells to infiltrate and attack the tumor cells.
Penn Medicine’s Carl June to receive 2024 Breakthrough Prize in Life Sciences
The Richard W. Vague Professor in Immunotherapy in the Perelman School of Medicine is honored for pioneering the development of CAR T cell therapy, which programs patients’ own immune cells to fight their cancer.
Can the COVID playbook help end malaria?
In a Perry World House conversation, Matthew Laurens, Martina Mchenga, and Drew Weissman discussed how lessons from a global pandemic could help in the fight to eradicate malaria.
The nursing burnout crisis is also happening in primary care
A study co-authored by Penn Nursing’s Jacqueline Nikpour and J. Margo Brooks Carthon finds nurses in primary care face burnout and poor work environments, especially in low-income clinics.
Genetic switch turns tumor suppressor into oncogene in colorectal cancer
Researchers from the School of Veterinary Medicine have shown that an enzyme that suppresses early-stage colorectal cancer switches to become an oncogene as the cancer progresses.
The new U.S. plan to target xylazine-laced fentanyl
Researchers from Penn LDI, in conjunction with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, analyze the plan and raise the question of whether it goes far enough.
In the News
UPenn hosts free online panel for LGBTQ+ workplace inclusion
The Eidos LGBTQ+ Health Initiative, led by José Bauermeister and Jessica Halem of the School of Nursing, will host a free online panel in April on the integration of LGBTQ+ people in the workforce.
FULL STORY →
How to die in good health
PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one.
FULL STORY →
Mayor Parker’s plan to ‘remove the presence of drug users’ from Kensington raises new questions
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
Homeward bound: When a Penn Medicine nurse was diagnosed with uterine cancer, she turned to the service dogs she helped to train
A profile highlights Maria Wright of Penn Medicine Lancaster General Health, from her volunteer work connecting people with service dogs to her cancer diagnosis and her own journey applying for a service dog.
FULL STORY →
How many patients would recommend their Philly-area hospital to family and friends? Check your local hospital
The Hospital of the University of Pennsylvania has been named one of the most recommended acute-care facilities by patients in the Philadelphia area.
FULL STORY →